Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

OVID Ovid Therapeutics Inc

3,121

-0,154 (-4,70%)

Zuletzt aktualisiert: 20:49:05

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Ovid Therapeutics Charts.

Ovid Therapeutics (NASDAQ:OVID)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Ovid Therapeutics Charts.

News Ovid Therapeutics Inc

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 14 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 14 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 14 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
Dienstag 14 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
Montag 13 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
Donnerstag 4 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Freitag 8 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 27 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Ovid Therapeutics Inc News-Artikel

JP Morgan Chase

Deutsche Telekom

Euro vs Sterling

Financial Select Sector

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen